Is it too late to buy Sigma Healthcare shares following this week's 22% surge?

The pharmacy operator and supplier had a mega announcement for the market yesterday.

| More on:
A senior pharmacist talks to a customer at the counter in a shop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The healthcare stock had an amazing day yesterday after Sigma announced a major contract win 
  • The deal is with Chemist Warehouse and is worth approximately $3 billion in annual sales for Sigma 
  • Sigma Healthcare shares have increased by 29% in the year to date 

Sigma Healthcare Ltd (ASX: SIG) shares are rising again today, up 1.55% to 79 cents at the time of writing.

This follows a mega announcement from the pharmacy operator and supplier yesterday that sent investors into a bit of a frenzy.

The healthcare share soared by 30% at one point yesterday after the company announced a massive new contract with Chemist Warehouse.

Sigma Healthcare estimates the deal is worth about $3 billion in annual sales to it.

The companies also renewed a contract that was generating approximately $1 billion in sales for Sigma.

As part of the deal, Chemist Warehouse will receive a 10.7% stake in Sigma Health.

Sigma Healthcare's CEO, Vikesh Ramsunder, commented:

The decision by Chemist Warehouse to award Sigma this supply contract is wonderful news for our company and our shareholders.

Sigma has worked tirelessly the past 12 months to build a stronger company and to significantly improve our operational performance for the benefit of all customers. Securing this Chemist Warehouse contract means we will now have real scale and momentum moving into the future.

Sigma Healthcare shares closed at 65 cents last Friday. They are up 22% this week so far.

Is it too late to buy Sigma Healthcare shares?

Shaw and Partners doesn't think so.

According to The Australian, the broker has responded to yesterday's big news by raising its rating on Sigma Healthcare shares to a buy.

It's been a positive year for the stock so far.

The company announced a return to profit back in March when it released its FY23 full-year results.

Sigma Healthcare announced a $1.8 million profit for FY23, up from a $7.2 million loss in FY22. 

As the chart below shows, Sigma Healthcare shares have increased by 29% in the year to date.

They have vastly outperformed the S&P/ASX 200 Health Care Index (ASX: XHJ), which is up 9.3% over the same period.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »